search
Back to results

Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

Primary Purpose

Sleep, Sleep Deprivation, Insufficient Sleep Syndrome

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sleep:wake 1
Sleep:wake 2
Sponsored by
Brigham and Women's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sleep focused on measuring Inpatients, Health Normalcy, circadian rhythm

Eligibility Criteria

18 Years - 35 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • Prescription medications

Sites / Locations

  • Brigham and Women's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Sleep:wake 2

Sleep:wake 1

Arm Description

Sleep and wake durations for arm 2 for inpatient portion of protocol. .There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 1.

Sleep and wake durations for arm 1 of the inpatient portion of the protocol. There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 2.

Outcomes

Primary Outcome Measures

Psychomotor Vigilance Task (PVT) performance
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.

Secondary Outcome Measures

Full Information

First Posted
March 22, 2012
Last Updated
July 15, 2016
Sponsor
Brigham and Women's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01581125
Brief Title
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
Official Title
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Brigham and Women's Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.
Detailed Description
The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase. Inpatient sleep and performance data will be collected from healthy volunteers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep, Sleep Deprivation, Insufficient Sleep Syndrome
Keywords
Inpatients, Health Normalcy, circadian rhythm

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
19 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sleep:wake 2
Arm Type
Experimental
Arm Description
Sleep and wake durations for arm 2 for inpatient portion of protocol. .There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 1.
Arm Title
Sleep:wake 1
Arm Type
Experimental
Arm Description
Sleep and wake durations for arm 1 of the inpatient portion of the protocol. There are a variety of sleep and wake durations during the protocol; some of these are longer and some are shorter and some are the same as in arm 2.
Intervention Type
Behavioral
Intervention Name(s)
Sleep:wake 1
Intervention Description
Sleep and Wake durations for arm 1
Intervention Type
Behavioral
Intervention Name(s)
Sleep:wake 2
Intervention Description
Sleep and Wake durations for arm2
Primary Outcome Measure Information:
Title
Psychomotor Vigilance Task (PVT) performance
Description
PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.
Time Frame
PVT during waking for arms 1 and 2 during the 32-day inpatient portion of the protocol

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Exclusion Criteria: Prescription medications
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth B Klerman, MD PhD
Organizational Affiliation
Brigham and Women's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
30722039
Citation
McHill AW, Hull JT, Cohen DA, Wang W, Czeisler CA, Klerman EB. Chronic sleep restriction greatly magnifies performance decrements immediately after awakening. Sleep. 2019 May 1;42(5):zsz032. doi: 10.1093/sleep/zsz032.
Results Reference
derived
PubMed Identifier
29946297
Citation
McHill AW, Hull JT, McMullan CJ, Klerman EB. Chronic Insufficient Sleep Has a Limited Impact on Circadian Rhythmicity of Subjective Hunger and Awakening Fasted Metabolic Hormones. Front Endocrinol (Lausanne). 2018 Jun 12;9:319. doi: 10.3389/fendo.2018.00319. eCollection 2018.
Results Reference
derived

Learn more about this trial

Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

We'll reach out to this number within 24 hrs